Mastronardi Luciano, Puzzilli Fabrizio
Division of Neurosurgery, Sandro Pertini Hospital, Rome, Italy.
Neurosurgery. 2003 May;52(5):1106-9; discussion 1109-10.
To investigate the impact of packing of intervertebral spaces with oxidized regenerated cellulose (ORC) on the incidence of recurrence of lumbar disc herniation (LDH).
We retrospectively reviewed 158 consecutive patients who underwent surgery for a newly diagnosed LDH and had a minimum of 18 months of follow-up. Single-level (151 patients) and two-level (7 patients) procedures accounted for 165 microdiscectomies. After microsurgical removal of disc herniation and curettage, the interspaces were tightly packed with ORC.
The average hospital stay was 1.47 days, without any relevant and permanent complications. In particular, complications related to intervertebral ORC packing were never observed. At a median follow-up of 29 months (range, 18-51 mo), the pain decreased or disappeared in almost all patients and the patient satisfaction rate was very high. A recurrence of LDH was observed in two patients (1.34%), both of whom needed a second operation. Three patients (2.01%) experienced a disc herniation involving another intervertebral space.
Our preliminary results suggest that the packing of intervertebral spaces with ORC at the end of microdiscectomy is a safe technique that may reduce the incidence of recurrent LDHs, although the true impact of this technique on long-term follow-up is still unclear. At the moment, it seems reasonable to assume that this technique should be used only under the auspices of large clinical investigations with prospective and randomized protocols.
探讨氧化再生纤维素(ORC)填充椎间隙对腰椎间盘突出症(LDH)复发率的影响。
我们回顾性分析了158例连续接受首次诊断为LDH手术且至少随访18个月的患者。单节段手术(151例患者)和双节段手术(7例患者)共进行了165例显微椎间盘切除术。在显微手术切除椎间盘突出并刮除后,椎间隙用ORC紧密填充。
平均住院时间为1.47天,无任何相关永久性并发症。特别是,从未观察到与椎间隙ORC填充相关的并发症。中位随访29个月(范围18 - 51个月)时,几乎所有患者的疼痛减轻或消失,患者满意度很高。2例患者(1.34%)出现LDH复发,均需再次手术。3例患者(2.01%)出现累及另一椎间隙的椎间盘突出。
我们的初步结果表明,显微椎间盘切除术后用ORC填充椎间隙是一种安全的技术,可能降低LDH复发率,尽管该技术对长期随访的真正影响仍不清楚。目前,似乎有理由认为该技术仅应在具有前瞻性和随机方案的大型临床研究的支持下使用。